The latest news updates from the 2024 Symposium
Three concurrent Special Sessions on Tuesday will cover topics including new drug approvals for metastatic breast cancer and the prevention, early detection, and interception of breast cancer. Amelie G. Ramirez, DrPH, MPH, will moderate a session and panel discussion on social determinants of health in cancer care.
Sessions throughout the Symposium will explore clinical cases from the perspective of experts including Martine J. Piccart, MD, PhD, and Virginia F. Borges, MD.
Kornelia Polyak, MD, PhD, FAACR, left, and Alana L. Welm, PhD, right, will be honored with awards from the American Association for Cancer Research (AACR) for significant contributions to breast cancer research.
Joshua Z. Drago, MD, MS, discusses a Tuesday afternoon presentation on antibody-drug conjugate development across tumor types.
Ashley M. Laughney, PhD, discusses a Tuesday afternoon presentation on the effect of cellular interactions with the tumor microenvironment based on intrinsic single cell variability.